63539-188-11 |
63539-188 |
HUMAN PRESCRIPTION DRUG |
Ibrance |
palbociclib |
CAPSULE |
ORAL |
20170508 |
N/A |
NDA |
NDA207103 |
U.S. Pharmaceuticals |
PALBOCICLIB |
100 mg/1 |
21 CAPSULE in 1 BOTTLE (63539-188-11) |
0069-0188-21 |
0069-0188 |
HUMAN PRESCRIPTION DRUG |
Ibrance |
palbociclib |
CAPSULE |
ORAL |
20150203 |
N/A |
NDA |
NDA207103 |
Pfizer Laboratories Div Pfizer Inc |
PALBOCICLIB |
100 mg/1 |
21 CAPSULE in 1 BOTTLE (0069-0188-21) |
63539-187-11 |
63539-187 |
HUMAN PRESCRIPTION DRUG |
Ibrance |
palbociclib |
CAPSULE |
ORAL |
20170508 |
N/A |
NDA |
NDA207103 |
U.S. Pharmaceuticals |
PALBOCICLIB |
75 mg/1 |
21 CAPSULE in 1 BOTTLE (63539-187-11) |
0069-0189-21 |
0069-0189 |
HUMAN PRESCRIPTION DRUG |
Ibrance |
palbociclib |
CAPSULE |
ORAL |
20150203 |
N/A |
NDA |
NDA207103 |
Pfizer Laboratories Div Pfizer Inc |
PALBOCICLIB |
125 mg/1 |
21 CAPSULE in 1 BOTTLE (0069-0189-21) |
63539-189-11 |
63539-189 |
HUMAN PRESCRIPTION DRUG |
Ibrance |
palbociclib |
CAPSULE |
ORAL |
20150203 |
N/A |
NDA |
NDA207103 |
U.S. Pharmaceuticals |
PALBOCICLIB |
125 mg/1 |
21 CAPSULE in 1 BOTTLE (63539-189-11) |
0069-0187-21 |
0069-0187 |
HUMAN PRESCRIPTION DRUG |
Ibrance |
palbociclib |
CAPSULE |
ORAL |
20150203 |
N/A |
NDA |
NDA207103 |
Pfizer Laboratories Div Pfizer Inc |
PALBOCICLIB |
75 mg/1 |
21 CAPSULE in 1 BOTTLE (0069-0187-21) |